VALENCIA GUILLAUME: Open Payments
NPI 1154977015 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $498 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| GENZYME CORPORATION | 2 | $65 |
| ABBVIE INC. | 2 | $59 |
| Incyte Corporation | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $32 |
| Organon LLC | 1 | $28 |
| Galderma Laboratories, L.P. | 1 | $23 |
| LEO Pharma Inc. | 1 | $17 |
Products named: TREMFYA, DUPIXENT, COSENTYX, SKYRIZI, OPZELURA, ILUMYA, NEMLUVIO, ADBRY.
Industry payments across NY — which companies pay providers there.
